BPGM

gene product
2,3-diphosphoglycerate (2,3-DPG) is a small molecule found at high concentrations in red blood cells where it binds to and decreases the oxygen affinity of hemoglobin. This gene encodes a multifunctional enzyme that catalyzes 2,3-DPG synthesis via its synthetase activity, and 2,3-DPG degradation via its phosphatase activity. The enzyme also has phosphoglycerate phosphomutase activity. Deficiency of this enzyme increases the affinity of cells for oxygen. Mutations in this gene result in hemolytic anemia. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
246 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
2 antibodies
Novus Biologicals
4 antibodies
antibodies-online
96 antibodies
LifeSpan BioSciences, Inc.
47 antibodies
Invitrogen Antibodies
4 antibodies
Biorbyt
9 antibodies
Abnova Corporation
4 antibodies
GeneTex
2 antibodies
OriGene
5 antibodies
Aviva Systems Biology
4 antibodies
Signalway Antibody LLC
1 antibody
NovoPro Bioscience Inc.
2 antibodies
Abbexa
1 antibody
St John's Laboratory
1 antibody
Proteintech Group
1 antibody
Acris Antibodies GmbH
4 antibodies
Abgent
1 antibody
Creative Biolabs
3 antibodies
Boster Biological Technology
1 antibody
RabMAbs
1 antibody
MyBioSource
6 antibodies
Creative Diagnostics
3 antibodies
Sigma-Aldrich
6 antibodies
United States Biological
25 antibodies
ProSci
1 antibody